Education
About Us
Working with TipRanks
Follow Us
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
Mrt-8102
Healthy Volunteers, Elevated Crp
Phase I
Recruiting
A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
Jul 30, 2025
―
Mrt-6160
Healthy Volunteers
Phase I
Completed
First-in-human Study of MRT-6160 in Healthy Subjects
Aug 02, 2024
―
Oral Mrt-2359
Prostate Cancer, Nsclc, Dlbcl, Sclc, High Grade Neuroendocrine Cancer, L-Myc And N-Myc Amplified Solid Tumors, Nsclc With High Or Low L-Myc Or N-Myc Expression, Hr-Positive, Her2-Negative Breast Cancer
Phase I/II
Recruiting
Study of Oral MRT-2359 in Selected Cancer Patients
Sep 16, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Monte Rosa Therapeutics (GLUE) have in its pipeline
GLUE is currently developing the following drugs: Mrt-8102, Mrt-6160, Oral Mrt-2359. These drug candidates are in various stages of clinical development as the company works toward FDA approval.